A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Giuliani, Cesidio ^a   Cerrone, Dominique ^a   Harii, Norikazu ^b   Thornton, Mark ^b   Kohn, Leonard D ^b   Dagia, Nilesh M ^c   Fiore, Emilio ^d   Bucci, Ines ^a   Chamblin, Tyler ^e   Vitti, Paolo ^d   Monaco, Fabrizio ^a   Napolitano, Giorgio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b OHIO UNIVERSITY   (United States)

^c US Institute of Navigation   (United States)

^d UNIVERSITY OF PISA   (Italy)

^e Quidel Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; STEROID; THIAMAZOLE; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHIMERA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EYE DISEASE; FEMALE; FUNCTIONAL ASSAY; GENETIC TRANSFECTION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HYPERTHYROIDISM; IMMUNOASSAY; ITALY; MAJOR CLINICAL STUDY; MALE; MC4 ASSAY; NONAUTOIMMUNE HYPERTHYROIDISM; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; THYROIDITIS; UNIVERSITY HOSPITAL; VALIDATION PROCESS; WILD TYPE;

ADULT; AGED; ANIMALS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELLS, CULTURED; CHO CELLS; CRICETINAE; FEMALE; GRAVES DISEASE; HEK293 CELLS; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; MINK; RECEPTORS, LH; RECEPTORS, THYROTROPIN; RECOMBINANT FUSION PROTEINS; THYROID FUNCTION TESTS;

EID: 84863566509     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2893     Document Type: Article

References (39)

1. Parmentier M, Libert F, Maenhaut C, Lefort A, Gerard C, Perret J, Van Sande J, Dumont JE, Vassart G 1989 Molecular cloning of the thyrotropin receptor. Science 246:1620-1622 (Pubitemid 20036700)
2. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190 (Pubitemid 20029833)
3. Akamizu T, Ikuyama S, Saji M, Kosugi S, Kozak C, McBride OW, Kohn LD 1990 Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc Natl Acad Sci USA 87:5677-5681
4. Adams DD, Purves HD 1956 Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med Sch 34:11
5. McKenzie JM 1965 Review: pathogenesis of Graves' disease: role of the long-acting thyroid stimulator. J Clin Endocrinol Metab 25:424-461
6. Saravanan P, Dayan CM 2001 Thyroid autoantibodies. Endocrinol Metab Clin North Am 30:315-337, viii (Pubitemid 32606677)
7. Kim TY, Park YJ, Park DJ, Chung HK, Kim WB, Kohn LD, Cho BY 2003 Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs. J Clin Endocrinol Metab 88:117-124 (Pubitemid 36115152)
8. Kohn LD, Giuliani C, Montani V, Napolitano G, Ohmori M, Ohta M, Saji M, Schuppert F, Shong MH, Suzuki K, Taniguchi SI, Yano K, Singer DS 1995 Antireceptor immunity. In: Rayner D, Champion B, eds. Thyroid immunity. Austin, TX: Landes Biomedical Publishers; 115-170
9. Orgiazzi J 2000 Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 29:339-355, vii (Pubitemid 30396234)
10. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL; AACE Thyroid Task Force 2002 AACE Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469
11. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593-646
12. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716 (Pubitemid 128506520)
13. Costagliola S, Vassart G 2002 Monoclonal antibodies with stimulating activity, at last. Thyroid 12:1039-1041 (Pubitemid 36114810)
14. Ando T, Latif R, Davies TF 2005 Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 19:33-52 (Pubitemid 40253948)
15. Tahara K, Ban T, Minegishi T, Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 179:70-77
16. Tahara K, Ishikawa N, Yamamoto K, Hirai H, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD 1997 Epitopes for thyroid stimulating and blocking antibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 7:867-877 (Pubitemid 28041661)
17. Kohn LD, Brown J, Scholl D, Li Y, Napolitano G 2009 Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease and assess disease severity. U.S. Patent Application 20090325177. Athens, OH: Diagnostic Hybrids, Inc.; December 31, 2009.
18. Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K, Koh CS 1996 Epitopes for thyroid stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. J Clin Endocrinol Metab 81:1758-1767
19. Watson PF, Ajian RA, Phipps J, Metcalfe R, Weetman AP 1998 A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease. Clin Endocrinol (Oxf) 49:577-581 (Pubitemid 28529754)
20. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglööhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH 1999 Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves'disease. J Clin Endocrinol Metab 84:90-97 (Pubitemid 29036685)
21. Evans C, Morgenthaler NG Lee S, Llewellyn DH, Clifton-Bligh R, John R, Lazarus JH, Chatterjee VK, Ludgate M 1999 Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab 84:374-377 (Pubitemid 29036730)
22. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A 1997 Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7:369-375 (Pubitemid 27295133)
23. Starrenburg-Razenberg AJ, Castro Cabezas M, Gan IM, Njo TL, Rietveld AP, Elte JWF 2010 Four patients with hypothyroid Graves'disease. Neth J Med 68:178-180
24. Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, Asawa T 1990 Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clin Endocrinol (Oxf) 33:687-698
25. Bech K, Bliddal H, Sierbaek-Nielsen K, Friis T 1982 Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves' disease after radioiodine administration. Clin Endocrinol 17:395-402 (Pubitemid 12064248)
26. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A 1998 Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyroid-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83:40-46 (Pubitemid 28498308)
27. Proust-Lemoine E, d'Herbomez M, Marchandise X, Wemeau JL 2011 Precocious hypothyroidism mechanisms after treatment in Graves' disease. Presse Med 40:e1-e8
28. Kim WB, Chung HK, Park, YJ, Park DJ, Tahara K, Kohn LD, Cho BY 2000 The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid 10:579-586 (Pubitemid 30670618)
29. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 Amonoclonal thyroid-stimulating antibody. J Clin Invest 110:1667-1674
30. Costagliola S, Franssen JD, Bonomi M, Urizar E, Willnich M, Bergmann A, Vassart G 2002 TSH receptor antibody with stimulatory activity. Biochem Biophys Res Commun 299:891-896
31. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid stimulating monoclonal antibodies. Thyroid 12:1043-1050
32. Sanders J, Evans M, Premawardhana LD, Depraetere M, Jeffreys J, Richards T, Furmaniak J, Rees Smith B 2003 Human monoclonal thyroid stimulating antibody. Lancet 362:126-128 (Pubitemid 36831025)
33. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S, Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18:3020-3034 (Pubitemid 39577923)
34. McLachlan S, Rapoport B 2004 Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward. Clin Endocrinol (Oxf) 61:10-18 (Pubitemid 38951640)
35. Michalek K, Morshed SA, Latif R, Davies TF 2009 TSH receptor autoantibodies. Autoimmun Rev 9:113-116
36. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B 2002 Thyroid-stimulating antibodies in Graves disease preferentially recognize the free subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209-217 (Pubitemid 34787358)
37. Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111:1897-1904 (Pubitemid 38057734)
38. Liu C, Hermsen D, Domberg J, Graeber C, Hautzel H, Duan Y, Xu KF, Liu CP, Mao XD, Cupisti K, Scherbaum WA, Schott M 2008 Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 40:479-483
39. Zöphel K, Roggenbuck D, von Landenberg P, Wunderlich G, Grüning T, Kotzerke J, Lackner KJ, Rees Smith B 2010 TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res 42:65-69